BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Medicinal products containing diacerein: recommendation of the Pharmacovigilance Risk Assessment Committee (PRAC) within a European safety review

Active substance: diacerein

The BfArM issues information on the PRAC's recommendation within the re-examination procedure following a European safety review in accordance with Article 31 of Directive 2001/83/EC.

To the risk assessment procedure (available in German only)

For details regarding the procedure please click on the following link to the European Medicines Agency (EMA):

Diacerein-containing medicines for oral administration